Related Experiment Videos
[The anticoagulant therapy of patients with dilated cardiomyopathy]
Vrachebnoe Delo
|November 1, 1990
Insights
Complex anticoagulant and deaggregant treatment in dilated cardiomyopathy patients significantly improved plasma hemostasis. Prolonged indirect anticoagulant use reduced thromboembolism by 12.1%.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Abstract:
Complex treatment with direct and indirect anticoagulants and deaggregants carried out in 41 patients with dilated cardiomyopathy produces a significant positive effect on the condition of plasma hemostasis allowing to control the signs of hypercoagulation changes of the general coagulation, fibrinogen-like and antiheparin activity leading to normalization of fibrinolysis of the euglobulin plasma fraction. Prolonged intake of indirect anticoagulants furthers reduction of development of thromboembolism by 12.1%.